About Multiple Sclerosis | Programs & Services | News Center | Publications | Site Preferences | Contact MSAA | Home
Search Clinical Trials Parent Therapeutic Areas: Neurology | Musculoskeletal
Multiple Sclerosis
State
Country
Alabama
Various Cities : Research Center New!
FREEDOMS II - Multiple Sclerosis Study
Arizona
Phoenix : Research Site:
A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
Tucson : Northwest NeuroSpecialists, PLLC
Clinical Research Study Available for People Diagnosed with Multiple Sclerosis
Multiple Sclerosis Study
California
Auburn : Sutter Institute for Medical Research (SIMR)
Multiple Sclerosis Data Collection Study
Berkeley : Research Site:
San Francisco : Research Site:
Colorado
Boulder : Alpine Clinical Research Center
Add-on Therapy of an oral medication for patients with Multiple Sclerosis, currently using Avonex, Betaseron, or Rebif.
New medicine for patients with Multiple Sclerosis experiencing Neuropathic Pain
New Oral medication for reducing the rate of clinical relapses in patients with Relapsing Remitting Multiple Sclerosis (MS)
Centennial : 1st International Clinical Research Center
Do you have Relapsing Remitting Multiple Sclerosis?
Connecticut
Florida
Bradenton : Research Site:
Bradenton : Bradenton Research
Bradenton Neurology, Inc. is participating in a nationwide research study for individuals who have been diagnosed with Multiple Sclerosis.
Vero Beach : Research Site:
Georgia
Atlanta : Research Site:
Atlanta : Neurotrials Research, Inc.
Have you experienced symptoms that suggest multiple sclerosis?
Illinois
Chicago : Research Site:
Indiana
Kansas
Kansas City : Research Site:
Lenexa : MidAmerica Neuroscience Institute
Relapsing forms of Multiple Sclerosis study to evaluate the safety and tolerability of two doses of an oral study drug over 24 weeks (study 7)
Kentucky
Lexington : Associates in Neurology, P.S.C.
A Phase 2 study of LY2127399, an AntiBaff Human Antibody vs placebo for subjects with Relapsing Remitting Multiple Sclerosis
A Phase 3 study of PEGylated Interferon Beta-1a vs Placebo for subjects with Relapsing Remitting Multiple Sclerosis.
Maryland
Baltimore : Research Site:
Massachusetts
Michigan
Bingham Farms : QUEST Research Institute
Treatment for Multiple Sclerosis (MS) - Associated Spasticity
Farmington Hills : Research Site:
Mississippi
Montana
Billings : Billings Clinic Research Center
Are you between the age of 18 and 65 with a diagnosis of Multiple Sclerosis?
New Hampshire
Lebanon : Research Site:
New Jersey
Lawrenceville : AdvanceMed Research
The Dignity studies are phase III international multicenter, double-blind, randomized, placebo-controlled trials of botulinum toxin (BOTOX) in patients with spinal cord injury (SCI) or multiple sclerosis (MS); BOTOX is not yet licensed for these indications.
New Mexico
Albuquerque : Research Site:
New York
Albany : Upstate Clinical Research, LLC
A Double-Blind, Placebo Controlled Multi-Center Study To Evaluate The Efficacy And Safety of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis
Mineola : Winthrop University Hospital Clinical Trials Center
Relapsing remitting multiple sclerosis
Volunteers needed for a multiple sclerosis research study
New York : Mount Sinai Medical Center
A 21 WEEK STUDY TO EVALUATE SAFETY AND EFFICACY OF ORAL FAMPRIDINE-SR IN SUBJECTS WITH MULTIPLE SCLEROSIS.
A 24-month, double-blind, randomized, multi-center, placebo-controlled, parallel-group study comparing the efficacy and safety of FTY720 1.25mg and 0.5mg administered once daily versus placebo in patients with relapsing remitting multiple sclerosis
New York : Research Site:
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon beta 1-a and Glatiramer Acetate to Either Agent Alone in Patients with Relapsing-Remitting Multiple Sclerosis (CombiRx Phase III)
A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis PROTOCOL: U2786g
ITN020AI: A Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patient with Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (MS) (STAYCIS)
New York : Biomedical Research Alliance of New York
Multiple Sclerosis treated with Betaseron® - Adults
OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in Multiple Sclerosis
The Establishment of a Patient Registry and Initiation of Related Projects of the New York State Multiple Sclerois Consortium
Plainview : Research Site:
Schenectady : Schenectady Neurological Consultants, PC
The TYSABRI Global Observational Program in Safety (TYGRIS) is a safety observational cohort study designed to obtain long-term safety data in multiple sclerosis (MS) patients treated with TYSABRI in a clinical practice setting.
Stony Brook : Research Site:
North Carolina
Charlotte : Research Site:
Salisbury : Central Carolina Neurology & Sleep, PA
Looking for MS Patients for a Quality of Life Study
Ohio
Cleveland : Research Site:
Columbus : Research Site:
Oklahoma
Oregon
Tualatin : Research Site:
Pennsylvania
South Carolina
Tennessee
Nashville : Research Site:
Texas
Houston : Research Site:
San Antonio : Research Site:
Vermont
Burlington : Research Site:
Virginia
Charlottesville : Research Site:
Belgium
Edegem : Research Site:
Sijsele-Damme : Research Site:
Bulgaria
Sofia : Research Site:
Canada
Montreal, QC : Research Site:
Toronto, ON : Research Site:
Vancouver, BC : Research Site:
Czech Republic
Ostrava : Research Site:
Pardubice : Research Site:
Prague : Research Site:
Praha : Research Site:
Teplice : Research Site:
Denmark
Arhus : Research Site:
Finland
Helsinki : Research Site:
Turku : Research Site:
France
Bordeaux : Research Site:
Caen : Research Site:
Clermont-Ferrand : Research Site:
Lyon : Research Site:
Montpellier : Research Site:
Nimes : Research Site:
Germany
Berlin : Research Site:
Hamburg : Research Site:
Marburg : Research Site:
Tübingen : Research Site:
Ulm : Research Site:
Italy
Milano : Research Site:
Roma : Research Site:
Mexico
Aguascalientes : Research Site:
Chihuahua : Research Site:
Netherlands
Breda : Research Site:
Poland
Gdansk : Research Site:
Lodz : Research Site:
Lublin : Research Site:
Warszawa : Research Site:
Romania
Bucuresti : Research Site:
Targu Mures : Research Site:
Russian Federation
Ekaterinburg : Research Site:
Kazan : Research Site:
Moscow : Research Site:
Nizhny Novgorod : Research Site:
Tyumen : Research Site:
Serbia and Montenegro
Belgrade : Research Site:
Nis : Research Site:
Nova Sad : Research Site:
Slovakia
Banska Bystrica : Research Site:
Bratislava : Research Site:
Kosice : Research Site:
Nitra : Research Site:
Spisska Nova Ves : Research Site:
Spain
Barcelona : Research Site:
Madrid : Research Site:
Malaga : Research Site:
Sevilla : Research Site:
Valencia : Research Site:
Switzerland
Basel : Research Site:
Ukraine
Kharkov : Research Site:
Kiev : Research Site:
Propetrovsk : Research Site:
Vinnytsya : Research Site:
United Kingdom
Liverpool : Research Site:
Newcastle upon Tyne : Research Site:
Nottingham : Research Site:
Sheffield : Research Site:
